Y. Tanaka

Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c<7%

Y. Terauchi, H. Maeda, A. Kubota, 2013, Journal of Endocrinological Investigation.

Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes ( ASSET-K 1 ) to a target of HbA 1 c < 7 %

Y. Terauchi, H. Maeda, A. Kubota, 2022 .

Thermoelectric power of single crystals

H. Maeda, Y. Tanaka, H. Sekine, 1997 .

Enhanced Anti-tumour Effect of Cisplatin with Low-voltage Electrochemotherapy in Hamster Oral Fibrosarcoma

Y. Sugita, T. Nakashima, Y. Kameyama, 2005, The Journal of international medical research.